99.39
price down icon1.10%   -1.2516
 
loading
전일 마감가:
$100.64
열려 있는:
$100.26
하루 거래량:
1.25M
Relative Volume:
0.44
시가총액:
$17.27B
수익:
$381.03M
순이익/손실:
$-1.01B
주가수익비율:
-16.70
EPS:
-5.95
순현금흐름:
$-789.25M
1주 성능:
-6.02%
1개월 성능:
+42.74%
6개월 성능:
+44.16%
1년 성능:
+50.03%
1일 변동 폭
Value
$98.14
$100.47
1주일 범위
Value
$98.14
$106.83
52주 변동 폭
Value
$60.40
$106.83

Insmed Inc Stock (INSM) Company Profile

Name
명칭
Insmed Inc
Name
전화
908-977-9900
Name
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
직원
1,271
Name
트위터
@insmed
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
INSM's Discussions on Twitter

INSM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
INSM
Insmed Inc
99.44 17.27B 381.03M -1.01B -789.25M -5.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.75 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.09 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.57 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.67 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.00 28.51B 3.81B -644.79M -669.77M -6.24

Insmed Inc Stock (INSM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-13 개시 Jefferies Buy
2025-02-25 개시 RBC Capital Mkts Outperform
2024-04-23 개시 Truist Buy
2024-02-15 개시 Wolfe Research Outperform
2023-12-08 개시 Wells Fargo Overweight
2023-11-20 재개 JP Morgan Overweight
2023-07-26 개시 Guggenheim Buy
2022-12-09 개시 Mizuho Buy
2022-12-07 개시 Barclays Overweight
2022-11-18 개시 BofA Securities Buy
2022-04-27 개시 Goldman Buy
2021-12-06 개시 JP Morgan Overweight
2021-10-19 재개 Monness Crespi & Hardt Buy
2021-10-19 재개 Morgan Stanley Overweight
2021-10-08 개시 Cantor Fitzgerald Overweight
2021-04-26 재개 Credit Suisse Outperform
2020-12-17 개시 Berenberg Buy
2020-10-12 재개 Stifel Buy
2019-09-03 개시 Goldman Buy
2019-04-09 재확인 H.C. Wainwright Buy
2019-02-15 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 업그레이드 Goldman Neutral → Buy
2019-01-02 개시 Canaccord Genuity Buy
2018-08-06 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 개시 Goldman Neutral
2018-04-23 업그레이드 Credit Suisse Neutral → Outperform
2018-03-21 개시 Morgan Stanley Overweight
2018-01-18 개시 Credit Suisse Neutral
2017-09-05 재확인 Evercore ISI Outperform
2017-08-17 개시 Evercore ISI Outperform
2017-07-11 개시 Robert W. Baird Outperform
2016-03-15 개시 Stifel Buy
2015-11-09 다운그레이드 UBS Buy → Neutral
2015-10-06 재확인 H.C. Wainwright Buy
2015-06-09 개시 Citigroup Neutral
2014-03-26 재확인 HC Wainwright Buy
모두보기

Insmed Inc 주식(INSM)의 최신 뉴스

pulisher
Jun 18, 2025

Insider Sell: Roger Adsett Sells 10,686 Shares of Insmed Inc (INSM) - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Mizuho Reiterates Outperform Rating on Insmed (INSM), Boosts PT to $110 - Insider Monkey

Jun 18, 2025
pulisher
Jun 17, 2025

10 Best Growth Stocks to Buy According to Billionaires - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107 - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Is Insmed Stock Overvalued at $98? - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating - Insider Monkey

Jun 17, 2025
pulisher
Jun 16, 2025

Insmed Completes $750 Million Follow-On Public Offering - Global Legal Chronicle

Jun 16, 2025
pulisher
Jun 16, 2025

Is Insmed Stock Overvalued After The 45% Jump? - Forbes

Jun 16, 2025
pulisher
Jun 15, 2025

Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio? - Benzinga

Jun 15, 2025
pulisher
Jun 15, 2025

Insmed Inc (INSM) Soars 30% on Impressive Study - MSN

Jun 15, 2025
pulisher
Jun 13, 2025

Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results - Insider Monkey

Jun 13, 2025
pulisher
Jun 13, 2025

INSM September 19th Options Begin Trading - Nasdaq

Jun 13, 2025
pulisher
Jun 13, 2025

AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

Insmed (INSM) Soars After Raising $650 million - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Stock Jumps 29% on Encouraging PAH Study Results - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Finance Watch: Insmed Cashes In On Positive Data With $750m Offering - insights.citeline.com

Jun 12, 2025
pulisher
Jun 12, 2025

SEC Form 424B5 filed by Insmed Incorporated - Quantisnow

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed prices capital raise of $750 via stock offering - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed announces $650M public offering of common stock - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Stock Ends Volatile Session Lower, Pauses After Monumental 32% Weekly Surge - Daily Chhattisgarh News

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed aims to raise $750M in one of the largest stock offerings this year - Endpoints News

Jun 12, 2025
pulisher
Jun 12, 2025

Stocks To Watch: Insmed Sees RS Rating Jump To 93 - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed dips after $750 mln stock sale - TradingView

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed (INSM) Secures $750 Million Through Stock Offering - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed is an attractive, but expensive takeout meal - statnews.com

Jun 12, 2025
pulisher
Jun 12, 2025

INSM Increases Common Stock Offering to $750M | INSM Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Prices $750 Million Common Stock Offering - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Bank of America Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock Price - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Insmed Raises Massive $750M in Stock Offering to Advance Breakthrough Drug Pipeline - Stock Titan

Jun 12, 2025
pulisher
Jun 12, 2025

INSM: Mizuho Raises Price Target for Insmed to $110 | INSM Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

Insmed Prices Public Offering Of About 7.81 Mln Shares At $96.00/shr - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed raises $750 million in public offering of common stock By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Pricing of $750 Million Public Offering of Comm - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed raises $750 million in public offering of common stock - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Pricing Of $750 Million Public Offering Of Common Stock At $96 Per Share - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Pricing of $750 Million Public Offering of Common Stock - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

These 10 Stocks Are Flying High - Insider Monkey

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Plans $650M Public Offering of Common Stock | INSM - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed's drug for rare lung disease meets main goal in mid-stage trial - MSN

Jun 11, 2025
pulisher
Jun 11, 2025

Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM) - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

$100 Invested In Insmed 10 Years Ago Would Be Worth This Much Today - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Sees Price Target Boost Amid Strong PAH Data | INS - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Price Target Raised to $120 by HC Wainwright & Co. - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Plans $650M Stock Offering, Shares Fall - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed announces $650 million public offering of common stock - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed announces $650 million public offering of common stock By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Plans $650 Million Public Offering - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed announces $650M common stock offering - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed Announces Proposed $650 Million Public Offering of Common Stock | INSM Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Sees Boost with Positive Phase 2b Trial Results | - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insmed (INSM) Receives Boosted Price Target from Wells Fargo | I - GuruFocus

Jun 11, 2025

Insmed Inc (INSM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Insmed Inc 주식 (INSM) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Bonstein Sara
Chief Financial Officer
Jun 23 '25
Sale
101.78
57,765
5,879,089
93,536
$21.32
price down icon 0.15%
$36.00
price down icon 0.06%
$21.00
price up icon 1.52%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
자본화:     |  볼륨(24시간):